Men's experiences of eating disorder treatment: A qualitative systematic review of men-only studies
Abstract
WHAT IS KNOWN ON THE SUBJECT?: There is a widespread perception that eating disorders are predominantly women´s illnesses. Most studies in the field of eating disorders include predominantly women. Current eating disorder programmes are tailored to meet women´s needs. At the same time, studies show that the rate of eating disorders among men is rising. Men tend to seek help for their eating disorder late in the course of their illness; even when they do seek treatment, they run risk of being undiagnosed by health professionals. WHAT THE PAPER ADDS TO EXISTING KNOWLEDGE?: We assessed the current knowledge on how men think and feel about their eating disorders and explored how this may affect their help-seeking behaviours and how they go about managing their eating disorders. Men experience unique symptoms and issues that may translate into unique treatment needs. There is a call to re-evaluate the current status quo for men with eating disorders regarding access to and receiving treatment for their eating disorders. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: It is becoming an increasing priority to effectively treat men with eating disorders. Men need to be recognized as stakeholders in eating disorder-associated health care delivery. Healthcare professionals should receive training about the nature of eating disorders in men. Eating disorder-specific treatments will require adaptations to mirror the needs of individuals rather than particular gender/sex entities. ABSTRACT:…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.